Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$118.06
-0.9%
$112.54
$96.43
$153.84
$33.85B1.231.84 million shs1.60 million shs
Bruker Corporation stock logo
BRKR
Bruker
$41.20
-1.4%
$38.62
$34.10
$72.94
$6.33B1.161.69 million shs1.54 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$51.45
-0.8%
$49.71
$46.01
$83.62
$8.13B1.381.44 million shs1.92 million shs
Waters Corporation stock logo
WAT
Waters
$349.93
-0.7%
$347.78
$279.24
$423.56
$20.97B1.11469,163 shs429,411 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-0.95%+1.60%+5.57%+3.86%-8.93%
Bruker Corporation stock logo
BRKR
Bruker
-1.44%+6.38%+12.48%+2.03%-35.43%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-0.75%+4.36%+6.30%-10.29%-28.19%
Waters Corporation stock logo
WAT
Waters
-0.67%+2.04%+0.37%-1.55%+20.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.5989 of 5 stars
3.34.02.53.62.30.81.3
Bruker Corporation stock logo
BRKR
Bruker
4.9122 of 5 stars
4.21.01.73.81.95.01.9
Bio-Techne Corp stock logo
TECH
Bio-Techne
4.9653 of 5 stars
4.25.01.74.22.81.71.9
Waters Corporation stock logo
WAT
Waters
4.4568 of 5 stars
3.35.00.03.51.81.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.54
Moderate Buy$140.9219.37% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$52.8928.37% Upside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.45
Hold$72.0039.94% Upside
Waters Corporation stock logo
WAT
Waters
2.61
Moderate Buy$388.0010.88% Upside

Current Analyst Ratings Breakdown

Latest WAT, BRKR, TECH, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Bruker Corporation stock logo
BRKR
Bruker
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $50.00
6/26/2025
Waters Corporation stock logo
WAT
Waters
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$370.00 ➝ $375.00
6/24/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $125.00
6/5/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
5/30/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$135.00
5/30/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$59.00
5/29/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$150.00 ➝ $130.00
5/29/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$160.00 ➝ $155.00
5/29/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$150.00
5/22/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$159.00 ➝ $140.00
5/22/2025
Bruker Corporation stock logo
BRKR
Bruker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$50.00 ➝ $40.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B5.15$6.19 per share19.07$20.53 per share5.75
Bruker Corporation stock logo
BRKR
Bruker
$3.37B1.85$3.54 per share11.64$11.85 per share3.48
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.16B6.96$2.30 per share22.40$13.13 per share3.92
Waters Corporation stock logo
WAT
Waters
$2.96B7.04$15.02 per share23.30$30.80 per share11.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.0529.1519.423.6217.59%25.92%13.24%8/20/2025 (Estimated)
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5279.2313.082.812.31%19.47%5.95%8/5/2025 (Estimated)
Bio-Techne Corp stock logo
TECH
Bio-Techne
$168.10M$0.8262.7426.122.7410.89%13.17%10.17%8/6/2025 (Estimated)
Waters Corporation stock logo
WAT
Waters
$637.83M$11.0231.7524.843.4822.02%41.70%15.67%7/30/2025 (Estimated)

Latest WAT, BRKR, TECH, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q2 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.26$1.31+$0.05$0.75$1.63 billion$1.67 billion
5/7/2025Q1 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.46$0.47+$0.01$0.11$763.83 million$801.40 million
5/7/2025Q3 2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.51$0.56+$0.05$0.14$317.92 million$316.18 million
5/6/2025Q1 2025
Waters Corporation stock logo
WAT
Waters
$2.22$2.25+$0.03$2.03$655.50 million$661.71 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.84%N/A24.44%9 Years
Bruker Corporation stock logo
BRKR
Bruker
$0.200.49%N/A38.46%N/A
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.62%N/A39.02%N/A
Waters Corporation stock logo
WAT
Waters
N/AN/AN/AN/AN/A

Latest WAT, BRKR, TECH, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.24800.9%7/1/20257/1/20257/23/2025
5/12/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.5%6/16/20256/16/20256/27/2025
5/19/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.67%5/19/20255/19/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.55
2.09
1.60
Bruker Corporation stock logo
BRKR
Bruker
1.13
1.57
0.74
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.16
3.71
2.58
Waters Corporation stock logo
WAT
Waters
0.69
1.81
1.28

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%
Waters Corporation stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Bio-Techne Corp stock logo
TECH
Bio-Techne
3.90%
Waters Corporation stock logo
WAT
Waters
0.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900284.07 millionN/AOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.53 million110.16 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,100156.77 million150.65 millionOptionable
Waters Corporation stock logo
WAT
Waters
7,60059.51 million59.02 millionOptionable

Recent News About These Companies

Why Townsville could be Waters' way back into title fight
Alarming starfish disease reaches Florida waters
Boat catches fire in waters off Miami Beach
Waters survives chaos, impresses in NASCAR cameo
Waters Edge project faces uncertainty after key partner exits

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$118.06 -1.11 (-0.93%)
Closing price 06/30/2025 03:58 PM Eastern
Extended Trading
$117.12 -0.94 (-0.80%)
As of 09:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$41.20 -0.60 (-1.44%)
Closing price 06/30/2025 04:00 PM Eastern
Extended Trading
$41.06 -0.14 (-0.34%)
As of 09:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$51.45 -0.39 (-0.75%)
Closing price 06/30/2025 04:00 PM Eastern
Extended Trading
$51.42 -0.03 (-0.05%)
As of 09:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Waters stock logo

Waters NYSE:WAT

$349.93 -2.48 (-0.70%)
Closing price 06/30/2025 03:58 PM Eastern
Extended Trading
$344.26 -5.68 (-1.62%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.